Clear 8°. Wind Chill: -8°. Wind: SW 6 mph.
Loading advertisement…
Trending: ‘Severe’ geomagnetic storm could make northern lights visible in southern US
HomeNewsNationalHealth ( Page 67)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

22 candidates vying for Illinois’ Democrat, Republican U.S. Senate primary

(The Center Square) – Some of the 22 candidates vying for their party’s nomination for the U.S. Senate seat being vacated by Dick Durbin say their focus is on kitchen table issues. ...
by

Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up

(Reuters) -Novo Nordisk and Pfizer have revised their bids for Metsera, the obesity drug developer said on Tuesday. Novo’s revised offer brings the deal value to about $10 billion, while Pfizer is now willing to shell out $8.1 billion. The revised bids come as both companies ...
by

Illinois quick hits: Ceremonies planned for new lawyers; energy efficiency grants announced

Ceremonies planned for new lawyers Bar admission ceremonies are scheduled across the state Wednesday for the 1,637 people who passed the July 2025 Bar Exam. ...
by

Illinois biz leader: Diversity computer snafu so bad it ‘has to be intentional’

(The Center Square) – An Illinois computer problem that has led to the diversity decertifications of numerous businesses owned by minorities and women in the past 15 months is financially disastrous and unacceptable, according to the leader of the Illinois State Black Chamber of ...
by

WATCH: GOP U.S. Sen. candidate Tracy on shutdown, tariffs; state expands sanctuary

(The Center Square) – In today's edition of Illinois in Focus Daily, The Center Square Editor Greg Bishop talks live with Republican U.S. Senate candidate Don Tracy about the government shutdown, politics over immigration, the use of tariffs and more. ...
by

Henry Schein lifts annual forecast on strong dental, medical equipment sales

(Reuters) -Medical equipment distributor Henry Schein raised its annual profit forecast after beating Wall Street estimates for third-quarter results on Tuesday, driven by strong sales in its dental and medical units. Shares of the Melville, New York-based company were up 8.3% in premarket trading. The ...
Loading advertisement…
by

Mandatory bird housing imposed in England as bird flu spreads

LONDON (Reuters) -Britain on Tuesday imposed a mandatory housing measure for birds covering the whole of England, effective Thursday, in a bid to slow the spread of bird flu. The disease is spreading rapidly in Europe, with the highest number of countries in at least ...
by

Waters Corp raises annual profit forecast on stronger lab equipment demand

(Reuters) -Lab equipment maker Waters Corp raised its annual profit forecast on Tuesday, after beating third-quarter profit estimates on improved demand from biotech clients for its tools used in drug development and research.  The Milford, Massachusetts-based company expects annual adjusted profit per share in the ...
by

Zoetis trims annual revenue forecast on muted demand for animal treatments

(Reuters) -Animal healthcare company Zoetis on Tuesday trimmed its annual revenue forecast on expectations of softer demand for its medicines and vaccines for pets and livestock, sending its shares down over 8% in premarket trading. Despite a rebound in veterinary visits, Zoetis experienced subdued ...
by

On eve of UN climate talks in Brazil, a call for less talking and more doing

BELEM, Brazil (AP) — For 30 years, world leaders and diplomats have gathered at United Nations negotiating sessions to try to curb climate change, but Earth’s temperature continues to rise and extreme weather worsens. So this month, they’re hoping for fewer promises and more action. Past ...
by

Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight

By Maggie Fick and Bhanvi Satija LONDON (Reuters) -Novo Nordisk’s new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues a bidding war with U.S. rival Pfizer. The drugmaker will release third quarter results on Wednesday, ...
by

Compass Pathways to expedite launch timing of its experimental depression therapy

(Reuters) -Drug developer Compass Pathways said on Tuesday it is pulling forward the expected launch timing of its experimental psilocybin-based depression therapy by 9 to 12 months. The decision follows the completion of enrollment for a late-stage study for the psychedelic-based therapy, COMP360, as well ...
First Previous636465666768697071Next Last